Avlar is a biotechnology venture capital company which currently has over Euro150 million under management in Avlar BioVentures Fund I, Avlar BioVentures Fund II and the First Cambridge Gateway Fund. The funds are focused on seed and early-stage inve...Show all
Highfield Court
Church Lane
Cambs, CB23 8AG
United Kingdom
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2011-11-28 | Medical Device Innovations | Seed VC | $0.7M | YFM Equity Partners |
| 2009-10-12 | Crescendo Biologics | Seed VC | $7.1M | Aitua, Sofinnova Partners, and UK Innovation & Science Seed Fund |
| 2007-10-22 | CellCentric | Series A | $4.3M | Challenge Fund Trading Company, Morningside Ventures, Nesta Investment Management, Providence Investment, Takeda Ventures, and UK Innovation & Science Seed Fund |
| 2005-10-25 | CellCentric | Seed VC | $0.47M | Providence Investment |
| 2001-06-02 | Sterix | Unattributed VC | $11M | 3i Group, Johnson & Johnson Innovation, and Spark Ventures |
